Pleural Effusion: Clinical Trials

13 trials for Pleural Effusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 unknown. 13 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 213Unknown 13
Phase 13Unknown 3
Phase 31Unknown 1

Follow Pleural Effusion: new trials by email Literature Review of Pleural Effusion trials Research Report on Pleural Effusion

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion
bevacizumab and camrelizumab - Malignant Pleural Effusion
Phase 1 / Phase 2UnknownThe First Affiliated Hospital of Zhengzhou University552022-08-012022-04-15
A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites
BSG-001 - Malignant Pleural Effusion, Malignant Ascites
Phase 1 / Phase 2UnknownBioSyngen Pte Ltd582019-01-012018-11-08
Management of Malignant Pleural Effusion With Indwelling Pleural Catheter Versus Silver Nitrate Pleurodesis
Silver Nitrate, Indwelling Pleural Catheter - Pleural Effusion, Malignant
Phase 1 / Phase 2UnknownAssiut University502019-01-012018-12-20
A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC
Radiation, Chemotherapy - Malignant Pleural Effusion, Nonsmall Cell Lung Cancer, Stage IV
Phase 2UnknownGuizhou Medical University682018-09-012019-06-14
Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer
Bevacizumab - Malignant Pleural Effusion
Phase 2UnknownPeking University Cancer Hospital & Institute872016-10-012018-11-07
Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural Effusion
tumor derived microparticles, cisplatin - Malignant Pleural Effusion
Phase 2UnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology902016-01-012019-02-26
Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion
rAdp53, Cisplatin, rAdp53 plus cisplatin - Malignant Pleural Effusion
Phase 2UnknownShenzhen SiBiono GeneTech Co.,Ltd902015-06-012015-04-29
Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural Effusion
Drug-packaging microparticles - Malignant Pleural Effusion,, Malignant Ascites
Phase 2UnknownHuazhong University of Science and Technology302013-05-012013-10-01
Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion
Bevacizumab, Pulvis talci - Malignant Pleural Effusion
Phase 2UnknownTang-Du Hospital1832012-01-012014-02-04
Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population
Doxycycline, normal saline - Malignant Pleural Effusion
Phase 2UnknownOttawa Hospital Research Institute402011-06-012020-09-25
Safety and Effectiveness Study for Pleurodesis With Silver Nitrate in Malignant Pleural Effusion
Silver Nitrate - Malignant Pleural Effusion
Phase 2UnknownUniversity of Sao Paulo General Hospital602009-08-012010-05-18
Dornase Alfa and Urokinase for Kids With Pleural Empyema
Urokinase and Dornase alfa, Urokinase - Pleural Empyema
Phase 2 / Phase 3UnknownAzienda Ospedaliera di Padova942007-10-012008-05-12
Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion
ibuprofen, morphine sulfate, management of therapy complications - Metastatic Cancer
Phase 2UnknownOxford University Hospitals NHS Trust3202007-03-012009-07-08

Narrower conditions

Pleural Effusion, Malignant (12)  ·  Ascites (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Empyema, Pleural (1)  ·  Neoplasm Metastasis (1)  ·  Pain (1)

Broader conditions

Pleural Diseases (13)  ·  Respiratory Tract Diseases (13)  ·  Neoplasms (12)  ·  Neoplasms by Site (12)  ·  Pleural Neoplasms (12)  ·  Respiratory Tract Neoplasms (12)  ·  Thoracic Neoplasms (12)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Pathologic Processes (3)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Empyema (1)  ·  Infections (1)  ·  Inflammation (1)

Interventions

Bevacizumab (3)  ·  Cisplatin (2)  ·  Silver Nitrate (2)  ·  Doxycycline (1)  ·  Drug Therapy (1)  ·  Ibuprofen (1)  ·  Morphine (1)  ·  Pleurodesis (1)  ·  Radiation (1)  ·  Saline Solution (1)  ·  Urokinase-Type Plasminogen Activator (1)  ·  camrelizumab (1)  ·  dornase alfa (1)

Sponsors

Assiut University (1)  ·  Azienda Ospedaliera di Padova (1)  ·  BioSyngen Pte Ltd (1)  ·  Guizhou Medical University (1)  ·  Huazhong University of Science and Technology (1)  ·  Ottawa Hospital Research Institute (1)  ·  Oxford University Hospitals NHS Trust (1)  ·  Peking University Cancer Hospital & Institute (1)  ·  Shenzhen SiBiono GeneTech Co.,Ltd (1)  ·  Tang-Du Hospital (1)  ·  The First Affiliated Hospital of Zhengzhou University (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)  ·  University of Sao Paulo General Hospital (1)

Countries

China (6)  ·  Australia (1)  ·  Brazil (1)  ·  Canada (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Bo Huang, Ph.D (1)  ·  Feng Wang (1)  ·  Giorgio Stefanutti, MD (1)  ·  Jian Fang (1)  ·  K. Amjadi, MD, FRCPC (1)  ·  Lietao Li, MD (1)  ·  PierGiorgio Gamba, MD (1)  ·  Ricardo M Terra, MD (1)  ·  Robert Davies, MD (1)  ·  Yang Jin, doctor (1)

Results publications

PMID 16107633, PMID 16111068, PMID 16790519, PMID 16797681, PMID 16940982, PMID 18561992, PMID 18710781, PMID 21267391, PMID 22083202, PMID 23178954, PMID 23925664, PMID 25798278, PMID 35080187